Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis System

NHS BLOOD AND TRANSPLANT, BRISTOL

There is 1 contract in this contracting process.

Summary of the contracting process

NHS Blood and Transplant, based in Bristol, is at the planning stage of a procurement process concerning the support and maintenance of the LDL Removal Apheresis System. The procurement involves medical equipment, specifically consumables and maintenance services for the Fresenius Medical Care ART Universal machines located in Bristol and Leeds. This is a tender process under the industry category of medical equipment and repair services, with a key engagement deadline set for 6th May 2025. Suppliers interested in participating in this market engagement exercise are requested to express their interest by reaching out to the contact point, Carley Butcher. While currently in the planning stage, NHSBT anticipates further notices around mid-June, and the procurement process is set to potentially begin in August 2025, with the contract period lasting until July 2027, extendable up to 2029.

This tender represents a significant opportunity for businesses in the medical equipment and healthcare services industry to partner with a prestigious NHS authority. Companies that specialize in medical consumables, equipment repair, and maintenance services are well-suited to engage in this procurement process. Additionally, the project is open to small and medium enterprises (SMEs) as well as voluntary, community, and social enterprises (VCSEs), offering a diverse range of stakeholders the opportunity to enhance their growth in collaboration with NHS Blood and Transplant. Participating businesses can benefit from long-term service engagements across multiple NHS sites, providing a platform to showcase their capabilities in a high-impact healthcare environment.

This is an AI-generated summary 🚀

How useful is this summary?

Planning

Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis System

NHS BLOOD AND TRANSPLANT, BRISTOL

Contract Timeline

Publication Date

22nd April 2025 15:16:12 PM

Planning Deadline

6th May 2025 22:59:59 PM Expired
Contract Summary

NHSBT would like to consult the market to establish the likely level of interest for the consumables and maintenance where Low Density Lipoprotein removal is performed on Fresenius Medical Care (UK) Ltd. ART Universal machines at the following sites: Bristol and Leeds. NHS Blood and Transplant (NHBST) is a Special Health Authority within the NHS and is responsible for the provision of blood components and a range of associated laboratory and patient therapeutic services to hospitals in England and Wales. Therapeutic Apheresis Services (TAS) provide lifesaving and life-enhancing therapies to adults and children from across a range of clinical specialties. Patients receive treatment either at their hospital bedside or where clinically appropriate as an outpatient in an NHS Blood and Transplant (NHSBT) unit. NHSBT provides regional access to apheresis services from 11 dedicated units across England and Wales.
Contract Details

Open Contracting ID

ocds-h6vhtk-0505dc

Publication Source

Find a Tender Service

Procurement Stage

Planning

Procurement Method

N/A

Procurement Method Details

N/A

Procurement Category

Goods

Tender Suitability

Framework / DPS
Contract Classification

CPV Code(s)

CPV Division(s)
Awarding Authority

NHS BLOOD AND TRANSPLANT, BRISTOL

Buyer Name

Carley Butcher

Buyer Email

carley.butcher@nhsbt.nhs.uk

Buyer Phone

07553523824

Buyer Address

203 Longmead Rd, Avon

Bristol

BS16 7FG

United Kingdom

View contract on Find a Tender Service

Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis System

NHS BLOOD AND TRANSPLANT, BRISTOL

Contract Timeline

Contract Summary

Contract Details

Contract Classification

Awarding Authority